Table 1 Demographic and clinical characteristics of the 89 patients enrolled with mild CAP or SCAP.
Characteristics | Mild CAP(n = 14) | SCAP (survivor) (n = 43) | SCAP (death) (n = 32) | SCAP (survivor) vs Mild CAP | SCAP (death) vs Mild CAP | SCAP (death) vs SCAP (survivor) |
|---|---|---|---|---|---|---|
Age (n = 14/43/32) | 62.29 ± 14.90 | 58.56 ± 17.57 | 69.00 ± 15.64 | 0.4785 | 0.1812 | 0.0095** |
Sex (n = 14/43/32) | ||||||
Male | 6(42.86%) | 37(86.05%) | 24(75%) | 0.0011** | 0.0352* | 0.2246 |
Female | 8(57.14%) | 6(13.95%) | 8(25%) | |||
BMI(n = 13/38/27) | 24.39 ± 4.923 | 23.29 ± 2.957 | 22.82 ± 5.041 | 0.3388 | 0.3585 | 0.6374 |
Previous history | ||||||
Smoking (n = 13/42/32) | 6(46.15%) | 16(37.21%) | 10(31.25%) | 0.6043 | 0.3438 | 0.5411 |
Drinking (n = 13/42/32) | 2(15.38%) | 8(18.6%) | 3(9.38%) | 0.7648 | 0.5610 | 0.2466 |
Operation history (n = 13/42/29) | 4(30.77%) | 13(30.95%) | 9(31.03%) | 0.9900 | 0.9863 | 0.9941 |
Allergic history (n = 13/42/32) | 2(15.38%) | 4(9.52%) | 9(28.13%) | 0.5536 | 0.3674 | 0.0372* |
Comorbidities (n = 13/42/32) | 8(61.54%) | 36(85.71%) | 30(93.75%) | 0.0569 | 0.0069** | 0.2701 |
Cancer (n = 13/42/32) | 1(7.69%) | 7(16.67%) | 4(12.5%) | 0.4225 | 0.6418 | 0.6177 |
Chronic lung disease(n = 13/42/32) | 5(38.46%) | 11(26.19%) | 8(25%) | 0.3946 | 0.3665 | 0.9075 |
Diabetes(n = 13/42/31) | 0(0%) | 7(16.67%) | 7(22.58%) | 0.1151 | 0.0617 | 0.5258 |
Hypertension(n = 13/42/31) | 3(23.08%) | 13(30.95%) | 15(48.39%) | 0.5848 | 0.1192 | 0.1300 |
Cardiac insufficiency(n = 13/42/31) | 2(15.38%) | 5(11.9%) | 3(9.68%) | 0.7422 | 0.5863 | 0.3011 |
Renal insufficiency (n = 13/42/31) | 2(15.38%) | 5(11.9%) | 1(3.23%) | 0.7422 | 0.1443 | 0.1820 |
Cerebrovascular disease(n = 13/42/32) | 1(7.69%) | 3(7.14%) | 10(31.25%) | 0.6843 | 0.0956 | 0.0022** |
Neurological diseases (dementia, Parkinson’s, etc.) (n = 13/42/31) | 0(0%) | 2(4.76%) | 4(12.9%) | 0.4228 | 0.1743 | 0.2106 |
Mental disease (n = 13/42/30) | 0(0%) | 3(7.14%) | 2(6.67%) | 0.3217 | 0.3486 | 0.9080 |
Respiratory therapy (n = 14/41/30) | ||||||
Nasal tube oxygen | 8(57.14%) | 15(36.59%) | 15(50%) | 0.1782 | 0.6586 | 0.2583 |
Mask oxygen inhalation | 0(0%) | 2(4.88%) | 1(3.33%) | 0.3999 | 0.4895 | 0.7493 |
Nasal high flow humidified oxygen therapy (HFNC) | 0(0%) | 9(21.95%) | 3(10%) | 0.0553 | 0.2203 | 0.1844 |
Non-invasive mechanical ventilation (NIPPV) | 0(0%) | 1(2.44%) | 1(3.33%) | 0.5554 | 0.4895 | 0.8220 |
Invasive mechanical ventilation (IPP) | 0(0%) | 15(36.59%) | 10(33.33%) | 0.0080** | 0.0140* | 0.7769 |
